Anisamide-functionalized reversibly crosslinked chimeric polymersomes emerge as an "all-function-in-one" nanoplatform for efficient loading and targeted delivery of methotrexate disodium, a potent water-soluble anticancer drug, to sigma receptor overexpressing H460 nonsmall lung cancer xenografts in vivo, leading to markedly improved tumor-growth inhibition and survival rate and depleted adverse effects as compared to the clinically used formulation (Trexall).
Keywords: lung cancer; methotrexate sodium; polymersomes; reduction-sensitive; targeted delivery.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.